Clinical Trial Update: Noninterventional Study on Tolerability and Safety of One Strength Updosing With Novo-Helisen Depot House Dust Mites

View source ↗

Summary

Noninterventional study update assessing tolerability and safety of a single-strength updosing with Novo-Helisen Depot for house dust mite–related allergic cond…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Asthma
• Allergic Conjunctivitis
• Allergic Rhinitis

Drugs mentioned

• Novo-Helisen Depot

Snippet

Sponsor: Allergopharma GmbH & Co. KG | Conditions: Allergic Rhinitis Due to House Dust Mite, Allergic Conjunctivitis Due to Dermatophagoides Farinae | Status: NOT_YET_RECRUITING